Flumizole, a new nonsteroidal anti-inflammatory agent

Area of Science:

• Pharmacology
• Drug Delivery
• Medicinal Chemistry

Background:

• Flumizole is a potent anti-inflammatory agent with superior efficacy compared to indomethacin in animal models.
• Poor water solubility of solid flumizole limits its gastrointestinal absorption.
• Development of advanced drug delivery systems is crucial for poorly soluble compounds.

Purpose of the Study:

• To enhance the absorption and dissolution properties of flumizole.
• To develop a novel solid dispersion formulation of flumizole using polyethylene glycol 6000.
• To evaluate the pharmacokinetic profile of the flumizole solid dispersion in various species.

Main Methods:

• Preparation of flumizole solid dispersion with polyethylene glycol 6000.
• In vitro dissolution testing in simulated gastric fluid.
• In vivo pharmacokinetic studies in rats, dogs, and human volunteers.

Main Results:

• The flumizole solid dispersion demonstrated a significantly increased dissolution rate compared to unformulated flumizole.
• Improved gastrointestinal absorption and bioavailability were observed in dogs with the solid dispersion.
• Human volunteer studies indicated good drug absorption, with rapid achievement and short half-life (2-7 hr) of plasma flumizole levels.

Conclusions:

• Flumizole solid dispersion formulation effectively enhances dissolution and absorption of the poorly water-soluble drug.
• This formulation represents a promising approach for improving the therapeutic potential of flumizole.
• The developed solid dispersion ensures favorable pharmacokinetic profiles across species, including humans.